Nifty
:
23547.75
Sensex
:
74775.74
-359.40 (-1.50%)
-1092.06 (-1.44%)
Nifty
Sensex
:
:
23547.75
74775.74
-359.40 (-1.50%)
-1092.06 (-1.44%)

Global Health Ltd.

Hospital & Healthcare Services

Rating :
62/99

BSE: 543654 | NSE: MEDANTA

NSE BSE
1189.00
29-May-2026
  • Open
  • High
  • Low
  • Previous Close
  •  1204.2
  •  1232.9
  •  1170
  •  1207.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  161671
  •  194923428.1
  •  1456.5
  •  956

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 31,801.68
  • 57.15
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 31,302.53
  • 0.04%
  • 8.01

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 33.01%
  • 7.27%
  • 5.88%
  • FII
  • DII
  • Others
  • 10.15%
  • 14.53%
  • 29.16%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.33
  • 20.61
  • 10.86

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.06
  • 34.30
  • 6.22

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.96
  • 75.63
  • 13.87

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 62.37

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 9.60

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 33.05

Earnings Forecasts:

(Updated: 30-05-2026)
Description
2024
2025
2026
2027
Adj EPS
20.34
25.71
31.85
36.15
P/E Ratio
58.46
46.25
37.33
32.89
Revenue
4365.35
5165.5
5935.16
6811.86
EBITDA
911.8
1174.2
1419.95
1594.91
Net Income
541.58
690.46
855.19
970.89
ROA
10.39
11.41
11.91
11.4
P/B Ratio
8.14
6.86
5.82
5.05
ROE
14.74
16.01
16.76
16.68
FCFF
98.7
211.85
289.39
411.33
FCFF Yield
0.29
0.63
0.86
1.22
Net Debt
-585.47
-185.52
-371.31
-290.9
BVPS
146.11
173.21
204.15
235.25

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
1,159.05
931.25
24.46%
1,121.05
943.44
18.83%
1,099.22
956.55
14.92%
1,030.84
861.08
19.71%
Expenses
915.28
706.56
29.54%
903.75
705.67
28.07%
868.28
728.27
19.23%
803.85
674.75
19.13%
EBITDA
243.76
224.69
8.49%
217.30
237.76
-8.61%
230.94
228.29
1.16%
226.98
186.32
21.82%
EBIDTM
21.03%
24.13%
19.38%
25.20%
21.01%
23.87%
22.02%
21.64%
Other Income
36.74
22.93
60.23%
21.78
16.02
35.96%
19.73
18.22
8.29%
20.46
21.93
-6.70%
Interest
26.71
15.03
77.71%
21.51
16.27
32.21%
17.11
15.97
7.14%
13.79
17.98
-23.30%
Depreciation
66.52
49.25
35.07%
61.19
48.45
26.30%
49.73
49.43
0.61%
45.11
46.62
-3.24%
PBT
187.28
133.44
40.35%
119.78
189.07
-36.65%
199.81
181.10
10.33%
208.14
143.65
44.89%
Tax
45.63
32.06
42.33%
24.75
46.21
-46.44%
41.41
50.28
-17.64%
49.16
37.39
31.48%
PAT
141.65
101.38
39.72%
95.03
142.86
-33.48%
158.40
130.82
21.08%
158.98
106.26
49.61%
PATM
12.22%
10.89%
8.48%
15.14%
14.41%
13.68%
15.42%
12.34%
EPS
5.36
3.78
41.80%
3.54
5.32
-33.46%
5.89
4.87
20.94%
5.92
3.96
49.49%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
4,410.16
3,692.32
3,275.11
2,709.88
2,167.30
1,446.74
1,500.42
1,441.13
1,343.21
1,277.18
1,382.05
Net Sales Growth
19.44%
12.74%
20.86%
25.03%
49.81%
-3.58%
4.11%
7.29%
5.17%
-7.59%
 
Cost Of Goods Sold
996.81
879.67
759.36
615.24
532.97
343.66
319.00
324.92
313.43
284.58
363.07
Gross Profit
3,413.35
2,812.65
2,515.75
2,094.63
1,634.32
1,103.09
1,181.42
1,116.22
1,029.79
992.60
1,018.98
GP Margin
77.40%
76.18%
76.81%
77.30%
75.41%
76.25%
78.74%
77.45%
76.67%
77.72%
73.73%
Total Expenditure
3,491.16
2,832.02
2,466.17
2,073.63
1,709.22
1,249.84
1,308.78
1,298.91
1,217.83
1,154.93
1,080.57
Power & Fuel Cost
-
62.12
59.91
57.12
47.06
38.56
34.60
30.65
29.55
30.63
29.22
% Of Sales
-
1.68%
1.83%
2.11%
2.17%
2.67%
2.31%
2.13%
2.20%
2.40%
2.11%
Employee Cost
-
822.41
732.89
635.65
567.96
466.34
538.78
541.08
526.64
519.47
471.87
% Of Sales
-
22.27%
22.38%
23.46%
26.21%
32.23%
35.91%
37.55%
39.21%
40.67%
34.14%
Manufacturing Exp.
-
653.26
560.63
422.07
358.73
231.24
145.04
89.87
109.48
39.99
29.97
% Of Sales
-
17.69%
17.12%
15.58%
16.55%
15.98%
9.67%
6.24%
8.15%
3.13%
2.17%
General & Admin Exp.
-
346.51
303.03
266.49
188.27
146.23
252.56
279.17
220.39
258.51
101.94
% Of Sales
-
9.38%
9.25%
9.83%
8.69%
10.11%
16.83%
19.37%
16.41%
20.24%
7.38%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
68.05
50.35
77.06
14.24
23.82
18.80
33.23
18.34
21.76
0.00
% Of Sales
-
1.84%
1.54%
2.84%
0.66%
1.65%
1.25%
2.31%
1.37%
1.70%
6.11%
EBITDA
918.98
860.30
808.94
636.25
458.08
196.90
191.64
142.22
125.38
122.25
301.48
EBITDA Margin
20.84%
23.30%
24.70%
23.48%
21.14%
13.61%
12.77%
9.87%
9.33%
9.57%
21.81%
Other Income
98.71
104.96
74.66
49.29
38.52
31.41
43.84
64.86
48.96
66.83
45.34
Interest
79.12
74.35
83.78
86.33
86.32
72.64
56.56
21.14
28.29
23.01
14.30
Depreciation
222.55
193.75
172.73
149.91
129.71
123.21
115.04
90.71
86.36
80.66
70.38
PBT
715.01
697.15
627.10
449.29
280.56
32.47
63.89
95.22
59.69
85.40
262.14
Tax
160.95
165.94
149.04
123.21
84.36
3.66
27.54
34.22
26.75
34.70
91.93
Tax Rate
22.51%
25.64%
23.77%
27.42%
30.07%
11.27%
43.11%
35.94%
44.81%
40.67%
35.07%
PAT
554.06
481.44
478.19
326.08
196.20
28.81
36.33
61.00
32.94
50.62
170.23
PAT before Minority Interest
556.46
481.32
478.06
326.08
196.20
28.81
36.33
61.00
32.94
50.62
170.21
Minority Interest
2.40
0.12
0.13
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.02
PAT Margin
12.56%
13.04%
14.60%
12.03%
9.05%
1.99%
2.42%
4.23%
2.45%
3.96%
12.32%
PAT Growth
15.11%
0.68%
46.65%
66.20%
581.01%
-20.70%
-40.44%
85.19%
-34.93%
-70.26%
 
EPS
20.61
17.91
17.79
12.13
7.30
1.07
1.35
2.27
1.23
1.88
6.33

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
3,386.41
2,905.63
2,428.21
1,616.01
1,382.34
1,349.54
1,305.17
1,217.20
1,139.15
1,056.95
Share Capital
53.72
53.70
53.64
50.64
82.09
81.84
81.63
80.99
80.99
80.72
Total Reserves
3,332.44
2,847.54
2,369.43
1,559.84
1,267.93
1,219.26
1,169.86
1,061.80
1,015.71
964.12
Non-Current Liabilities
726.88
719.42
1,089.49
1,586.27
1,299.73
1,008.81
675.60
432.30
241.60
188.86
Secured Loans
264.10
235.96
659.47
717.17
551.43
540.74
449.02
228.71
23.73
113.34
Unsecured Loans
0.00
47.51
77.65
50.46
26.27
64.78
139.95
106.93
108.45
0.00
Long Term Provisions
66.17
57.74
54.04
555.12
460.70
85.81
30.72
17.10
16.90
12.74
Current Liabilities
618.82
617.73
572.55
419.48
404.66
357.66
278.60
334.32
271.88
238.27
Trade Payables
194.81
186.78
194.69
134.33
131.55
130.74
126.46
106.16
104.35
91.88
Other Current Liabilities
376.61
394.48
352.09
265.84
245.40
207.99
142.60
133.59
109.40
109.51
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
0.00
67.40
30.27
11.12
Short Term Provisions
47.40
36.48
25.78
19.31
27.72
18.93
9.54
27.17
27.86
25.75
Total Liabilities
4,733.21
4,242.75
4,090.25
3,621.76
3,086.73
2,716.01
2,259.37
1,983.82
1,652.63
1,484.57
Net Block
2,514.01
2,235.91
2,050.09
1,775.86
1,615.67
1,703.11
1,029.93
1,088.71
972.24
913.89
Gross Block
3,604.50
3,145.64
2,877.28
2,457.99
2,172.59
2,140.90
1,359.17
1,328.05
1,125.92
1,222.87
Accumulated Depreciation
1,090.50
909.73
827.19
682.13
556.92
437.79
329.24
239.34
153.68
308.98
Non Current Assets
3,200.08
2,734.02
2,510.77
2,810.03
2,584.60
2,237.41
1,768.91
1,511.84
1,025.32
975.77
Capital Work in Progress
533.34
387.54
326.98
439.25
463.82
381.73
655.96
317.03
10.34
11.72
Non Current Investment
2.71
0.05
0.05
0.05
0.05
0.00
0.00
4.84
4.91
0.00
Long Term Loans & Adv.
119.88
92.87
99.61
583.22
485.93
128.04
79.30
73.59
35.35
14.67
Other Non Current Assets
30.15
17.65
34.05
11.64
19.13
24.53
3.72
27.67
2.47
35.49
Current Assets
1,533.12
1,508.73
1,579.49
811.73
502.13
478.60
490.46
471.98
627.31
508.79
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
67.14
66.85
60.37
53.39
39.76
38.52
23.29
22.73
21.43
27.70
Sundry Debtors
291.86
215.31
194.20
180.20
133.63
149.15
164.18
151.81
106.79
75.44
Cash & Bank
1,122.34
1,175.28
1,278.10
511.81
289.30
250.12
266.45
260.21
469.65
376.10
Other Current Assets
51.79
17.18
18.99
46.10
39.45
40.80
36.54
37.23
29.43
29.55
Short Term Loans & Adv.
27.98
34.11
27.82
20.23
16.05
8.60
13.69
14.19
12.65
12.74
Net Current Assets
914.31
891.00
1,006.93
392.24
97.47
120.93
211.86
137.66
355.43
270.53
Total Assets
4,733.20
4,242.75
4,090.26
3,621.76
3,086.73
2,716.01
2,259.37
1,983.82
1,652.63
1,484.56

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 16
Cash From Operating Activity
623.76
612.08
644.52
311.26
241.77
175.07
227.60
PBT
647.26
627.10
449.29
280.56
32.46
63.89
262.14
Adjustment
240.44
208.36
198.55
195.49
189.11
165.28
77.68
Changes in Working Capital
-99.70
-45.91
102.82
-66.77
36.59
2.07
-14.81
Cash after chg. in Working capital
788.00
789.55
750.66
409.28
258.17
231.24
325.01
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-164.24
-177.46
-106.14
-98.02
-16.40
-56.18
-97.41
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-720.94
-440.80
-342.35
-420.88
-239.15
-87.07
-240.66
Net Fixed Assets
-528.63
-1,223.87
-131.36
-58.22
-4.23
-129.70
Net Investments
-3.91
403.39
-30.97
-108.47
-125.05
-486.48
Others
-188.40
379.68
-180.02
-254.19
-109.87
529.11
Cash from Financing Activity
-97.23
-513.92
345.64
159.59
-80.72
-0.88
-6.60
Net Cash Inflow / Outflow
-194.41
-342.63
647.81
49.97
-78.11
87.12
-19.66
Opening Cash & Equivalents
424.61
767.24
119.43
69.47
147.57
60.45
62.33
Closing Cash & Equivalent
230.20
424.61
767.24
119.43
69.47
147.57
42.67

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Book Value (Rs.)
126.07
108.05
90.35
63.60
53.14
257.09
ROA
10.72%
11.47%
8.46%
5.85%
0.99%
1.46%
ROE
15.31%
17.96%
16.17%
13.40%
2.23%
2.92%
ROCE
20.50%
21.56%
18.71%
16.38%
5.26%
6.20%
Fixed Asset Turnover
1.09
1.09
1.02
0.94
0.67
0.86
Receivable days
25.07
22.82
25.21
26.43
35.67
38.11
Inventory Days
6.62
7.09
7.66
7.84
9.87
7.52
Payable days
79.17
91.68
97.60
91.04
139.29
40.14
Cash Conversion Cycle
-47.48
-61.77
-64.72
-56.77
-93.75
5.49
Total Debt/Equity
0.10
0.14
0.35
0.52
0.48
0.48
Interest Cover
9.71
8.48
6.20
4.25
1.45
2.13

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Global Health - Quarterly Results
    15th May 2026, 00:00 AM

    Read More
  • Global Health planning to takeover 80 bedded Cancer Hospital in Indore
    27th Apr 2026, 15:42 PM

    Medanta will pay a consideration of Rs 30 crore for the transfer of business, including the assignment of the long-term lease

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.